[1]刘震,于训意,曹长征,等.接骨续筋丸促进大鼠骨折愈合的作用机制研究[J].中医正骨,2017,29(10):1-12.
　LIU Zhen,YU Xunyi,CAO Changzheng,et al.Study on mechanism of action of Jiegu Xujin Wan(接骨续筋丸)in promoting fracture healing in rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(10):1-12.
点击复制

接骨续筋丸促进大鼠骨折愈合的作用机制研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第29卷
期数:
2017年10期
页码:
1-12
栏目:
基础研究
出版日期:
2017-10-20

文章信息/Info

Title:
Study on mechanism of action of Jiegu Xujin Wan(接骨续筋丸)in promoting fracture healing in rats
作者:
刘震1; 于训意2; 曹长征2; 付伟1; 苏纪权1; 马贤德3; 侯德才2
1.辽宁省海城市正骨医院,辽宁 海城 114200; 2.辽宁中医药大学附属医院,辽宁 沈阳 110032; 3.辽宁中医药大学,辽宁 沈阳 110032
Author(s):
LIU Zhen1; YU Xunyi2; CAO Changzheng2; FU Wei1; SU Jiquan1; MA Xiande3; HOU Decai2
1.Haicheng Orthopedic-Traumatological Hospital,Haicheng 114200,Liaoning,China 2.The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,Liaoning,China 3.Liaoning University of Traditional Chinese Medicine,Shenyang 110032,Liaoning,China
关键词:
骨折愈合;  接骨续筋丸;  成骨细胞;  破骨细胞;  碱性磷酸酶;  骨形态发生蛋白质2;  血管内皮生长因子类;  钙;  磷;  大鼠;  动物实验
Keywords:
Key words fracture healing;  Jiegu Xujin Wan; osteoblasts;  osteoclasts;  alkaline phosphatase;  bone morphogenetic protein2;  vascular endothelial growth factors;  calcium;  phosphorus;  rats;  animal experimentation
摘要:
目的:探讨接骨续筋丸促进大鼠骨折愈合的作用机制。方法:将72只3月龄雄性SD大鼠随机分为假手术组、模型对照组、接骨七厘胶囊组、接骨续筋丸组,每组18只。截断模型对照组、接骨七厘胶囊组、接骨续筋丸组大鼠股骨干中段,制作股骨开放性骨折模型; 假手术组仅暴露股骨干,不做截骨。造模后第2天开始灌胃,接骨续筋丸组以3 g·kg-1剂量的接骨续筋丸混悬液灌胃,接骨七厘胶囊组以0.52 g·kg-1剂量的接骨七厘胶囊混悬液灌胃,模型对照组和假手术组给予蒸馏水灌胃; 每天灌胃1次,各组连续灌胃21 d。分别于药物干预7 d、14 d、21 d后取材,各组随机选取6只大鼠从腹主动脉抽血,经静置、离心后吸取上层血清,保存待检; 抽血完成后,取出大鼠左侧股骨干,制备骨折端股骨石蜡标本。分别采用钙(calcium,Ca)、磷(phosphorus,P)、血清碱性磷酸酶(alkaline phosphatase,ALP)测试盒测定大鼠血清Ca、P、ALP含量,采用苏木精-伊红(HE)染色观察骨组织形态学变化,采用免疫组化法检测骨折端骨组织中骨形态发生蛋白2(bone morphogenetic protein 2,BMP-2)和血管内皮生长因子(vascular endothelial growth factor,VEGF)的表达。结果:①药物干预后血清Ca含量。药物干预7 d、14 d、21 d 后,4组大鼠血清Ca含量比较,组间差异均无统计学意义[(1.80±1.03)mmol·L-1,(1.88±0.80)mmol·L-1,(1.91±0.68)mmol·L-1,(1.83±0.62)mmol·L-1,F=0.023,P=0.995;(1.77±0.89)mmol·L-1,(1.77±0.73)mmol·L-1,(1.88±1.18)mmol·L-1,(1.74±0.89)mmol·L-1,F=0.025,P=0.095;(1.72±0.98)mmol·L-1,(1.74±0.61)mmol·L-1,(1.80±0.90)mmol·L-1,(1.69±0.79)mmol·L-1,F=0.019,P=0.996]。②药物干预后血清P含量。药物干预7 d后,4组大鼠血清P含量比较,差异有统计学意义[(1.89±0.56)mmol·L-1,(1.97±0.53)mmol·L-1,(3.23±0.90)mmol·L-1,(4.24±0.68)mmol·L-1,F=16.041,P=0.000]; 组间两两比较,假手术组与模型对照组的差异无统计学意义(P=0.846),假手术组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.003),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.005),接骨七厘胶囊组低于接骨续筋丸组(P=0.018)。药物干预14 d后,4组大鼠血清P含量比较,差异有统计学意义[(1.81±0.48)mmol·L-1,(2.65±0.36)mmol·L-1,(3.73±0.77)mmol·L-1,(4.37±0.93)mmol·L-1,F=16.998,P=0.000]; 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.045,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.012),接骨七厘胶囊组与接骨续筋丸组的差异无统计学意义(P=0.116)。药物干预21 d后,4组大鼠血清P含量比较,差异有统计学意义[(1.82±0.40)mmol·L-1,(2.15±0.50)mmol·L-1,(3.35±0.62)mmol·L-1,(4.21±0.70)mmol·L-1,F=22.663,P=0.000]; 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.036,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.002),接骨七厘胶囊组低于接骨续筋丸组(P=0.016)。③药物干预后血清ALP含量。药物干预7 d后,4组大鼠血清ALP含量比较,差异有统计学意义[(49.71±14.67)U·L-1,(93.75±15.11)U·L-1,(125.00±22.89)U·L-1,(145.49±20.79)U·L-1,F=29.797,P=0.000]; 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000,P=0.001),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.001,P=0.000),接骨七厘胶囊组低于接骨续筋丸组(P=0.009)。药物干预14 d后,4组大鼠血清ALP含量比较,差异有统计学意义[(41.57±10.69)U·L-1,( 91.13±10.76)U·L-1,(111.77±19.66)U·L-1,(149.42±12.71)U·L-1,F=62.354,P=0.000]; 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000),接骨七厘胶囊组低于接骨续筋丸组(P=0.019)。药物干预21 d后,4组大鼠血清ALP含量比较,差异有统计学意义[(42.73±14.94)U·L-1,(77.33±15.54)U·L-1,(95.49±26.12)U·L-1,(124.85±25.34)U·L-1,F=15.847,P=0.000]; 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000,P=0.010),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.026,P=0.001); 接骨七厘胶囊组低于接骨续筋丸组(P=0.015)。④药物干预后骨折端骨组织形态。药物干预7 d后,模型对照组、接骨七厘胶囊组、接骨续筋丸组骨 折端骨组织中可见少量成骨细胞聚集; 药物干预14 d后成骨细胞显著增多,且接骨续筋丸组及接骨七厘胶囊组的成骨细胞数量较模型对照组明显增多; 药物干预21 d后成骨细胞开始减少; 3组破骨细胞在药物干预21 d后出现增长趋势。⑤药物干预后骨折端骨组织中BMP-2的表达量。药物干预7 d后,4组大鼠骨折端骨组织中BMP-2表达量比较,差异有统计学意义(0.10±0.01,0.14±0.02,0.23±0.03,0.27±0.03,F=59.960,P=0.000); 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.018,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000),接骨七厘胶囊组低于接骨续筋丸组(P=0.015)。药物干预14 d后,4组大鼠骨折端骨组织中BMP-2表达量比较,差异有统计学意义(0.12±0.02,0.15±0.02,0.24±0.03,0.28±0.03,F=47.588,P=0.000); 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.047,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000),接骨七厘胶囊组低于接骨续筋丸组(P=0.006)。药物干预21 d后,4组大鼠骨折端骨组织中BMP-2表达量比较,差异有统计学意义(0.11±0.02,0.15±0.02,0.24±0.03,0.28±0.02,F=80.017,P=0.000); 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.004,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000),接骨七厘胶囊组低于接骨续筋丸组(P=0.004)。⑥药物干预后骨折端骨组织中VEGF的表达量。药物干预7 d后,4组大鼠骨折端骨组织中VEGF表达量比较,差异有统计学意义(0.11±0.02,0.14±0.02,0.26±0.01,0.27±0.04,F=69.567,P=0.000); 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.015,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000),接骨七厘胶囊组与接骨续筋丸组的差异无统计学意义(P=0.905)。药物干预14 d后,4组大鼠骨折端骨组织中VEGF表达量比较,差异有统计学意义(0.11±0.02,0.15±0.02,0.25±0.03,0.28±0.02,F=72.334,P=0.000); 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.026,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000),接骨七厘胶囊组与接骨续筋丸组的差异无统计学意义(P=0.071)。药物干预21 d后,4组大鼠骨折端骨组织中VEGF表达量比较,差异有统计学意义(0.11±0.02,0.15±0.02,0.24±0.02,0.27±0.05,F=39.739,P=0.000); 组间两两比较,假手术组低于模型对照组、接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000,P=0.000),模型对照组低于接骨七厘胶囊组、接骨续筋丸组(P=0.000,P=0.000),接骨七厘胶囊组低于接骨续筋丸组(P=0.029)。结论:接骨续筋丸促进大鼠骨折愈合的作用机制可能是通过提高大鼠血清P、ALP的含量,促进其骨组织中BMP-2及VEGF的表达,从而促进成骨细胞增殖,但其具体作用机制有待进一步深入研究。
Abstract:
ABSTRACT Objective:To explore the mechanism of action of Jiegu Xujin Wan(接骨续筋丸,JGXJW)in promoting fracture healing in rats.Methods:Seventy-two 3-month-old male SD rats were randomly divided into sham-operated group,model group,Jiegu Qili Jiaonang(接骨七厘胶囊,JGQLJN)group and JGXJW group,18 cases in each group.The middle femoral shafts of rats in model group,JGQLJN group and JGXJW group were cut off to build open femoral fracture models,while the surgeries were performed on the rats in sham-operated group to expose their femoral shafts only.Since the 2nd day after the modeling operation,the rats in JGXJW group,JGQLJN group,model group and sham-operated group were intragastric administrated with JGXJW suspension(3 g/kg),JGQLJN suspension(0.52 g/kg)and distilled water respectively,once a day for 21 consecutive days.At 7,14 and 21 days after the beginning of drug intervention,6 rats were randomly selected from each group,and their blood were fetched out from aorta abdominalis.The upper serum was sucked from the blood samples after standing and centrifuging for further inspection.Then the rats were sacrificed and their left femoral shafts were fetched out for making femoral paraffin specimens.The serum contents of calcium(Ca),phosphorus(P)and alkaline phosphatase(ALP)were determined by using Ca,P and ALP assay kit.The morphological changes of bone tissues were observed after hematoxylin-eosin(HE)staining,and the expression of bone morphogenetic protein 2(BMP-2)and vascular endothelial growth factor(VEGF)in bone tissues of broken ends of fractured bone were detected by immunohistochemical method respectively.Results:There was no statistical difference in serum content of Ca between the 4 groups at 7,14 and 21 days after the beginning of drug intervention(1.80+/-1.03,1.88+/-0.80,1.91+/-0.68,1.83+/-0.62 mmol/l,F=0.023,P=0.995; 1.77+/-0.89,1.77+/-0.73,1.88+/-1.18,1.74+/-0.89 mmol/l,F=0.025,P=0.095; 1.72+/-0.98,1.74+/-0.61,1.80+/-0.90,1.69+/-0.79 mmol/l,F=0.019,P=0.996).At 7 days after the beginning of drug intervention,there was statistical difference in serum content of P between the 4 groups(1.89+/-0.56,1.97+/-0.53,3.23+/-0.90,4.24+/-0.68 mmol/l,F=16.041,P=0.000).Further pairwise comparison showed that there was no statistical difference in the serum content of P between sham-operated group and model group(P=0.846),and the serum content of P was lower in sham-operated group compared to JGQLJN group and JGXJW group(P=0.000,P=0.003),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.005),and was lower in JGQLJN group compared to JGXJW group(P=0.018).At 14 days after the beginning of drug intervention,there was statistical difference in serum content of P between the 4 groups(1.81+/-0.48,2.65+/-0.36,3.73+/-0.77,4.37+/-0.93 mmol/l,F=16.998,P=0.000).Further pairwise comparison showed that the serum content of P was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.045,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.012),and there was no statistical difference in serum content of P between JGQLJN group and JGXJW group(P=0.116).At 21 days after the beginning of drug intervention,there was statistical difference in serum content of P between the 4 groups(1.82+/-0.40,2.15+/-0.50,3.35+/-0.62,4.21+/-0.70 mmol/l,F=22.663,P=0.000).Further pairwise comparison showed that the serum content of P was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.036,P=0.000,P=0.000),and was lower in model group compard to JGQLJN group and JGXJW group(P=0.000,P=0.002),and was lower in JGQLJN group compared to JGXJW group(P=0.016).At 7 days after the beginning of drug intervention,there was statistical difference in serum content of ALP between the 4 groups(49.71+/-14.67,93.75+/-15.11,125.00+/-22.89,145.49+/-20.79 U/L,F=29.797,P=0.000).Further pairwise comparison showed that the serum content of ALP was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.000,P=0.000,P=0.001),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.001,P=0.000),and was lower in JGQLJN group compared to JGXJW group(P=0.009).At 14 days after the beginning of drug intervention,there was statistical difference in serum content of ALP between the 4 groups(41.57+/-10.69,91.13+/-10.76,111.77+/-19.66,149.42+/-12.71 U/L,F=62.354,P=0.000).Further pairwise comparison showed that the serum content of ALP was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.000,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.000),and was lower in JGQLJN group compared to JGXJW group(P=0.019).At 21 days after the beginning of drug intervention,there was statistical difference in serum content of ALP between the 4 groups(42.73+/-14.94,77.33+/-15.54,95.49+/-26.12,124.85+/-25.34 U/L,F=15.847,P=0.000).Further pairwise comparison showed that the serum content of ALP was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.000,P=0.000,P=0.010),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.026,P=0.001),and was lower in JGQLJN group compared to JGXJW group(P=0.015).At 7 days after the beginning of drug intervention,a small number of osteoblasts can be found in bone tissues of broken ends of fractured bone in model group,JGQLJN group and JGXJW group.At 14 days after the beginning of drug intervention,there was a notable increase in the number of osteoblasts,and the number of osteoblasts were greater in JGXJW group and JGQLJN group compared to model group.At 21 days after the beginning of drug intervention,the number of osteoblasts began to decrease while the number of osteoclasts began to increase.At 7 days after the beginning of drug intervention,there was statistical difference in the expression of BMP-2 in bone tissues of broken ends of fractured bone between the 4 groups(0.10+/-0.01,0.14+/-0.02,0.23+/-0.03,0.27+/-0.03,F=59.960,P=0.000).Further pairwise comparison showed that the expression of BMP-2 in bone tissues was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.018,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.000),and was lower in JGQLJN group compared to JGXJW group(P=0.015).At 14 days after the beginning of drug intervention,there was statistical difference in the expression of BMP-2 in bone tissues of broken ends of fractured bone between the 4 groups(0.12+/-0.02,0.15+/-0.02,0.24+/-0.03,0.28+/-0.03,F=47.588,P=0.000).Further pairwise comparison showed that the expression of BMP-2 in bone tissues was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.047,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.000),and was lower in JGQLJN group compared to JGXJW group(P=0.006).At 21 days after the beginning of drug intervention,there was statistical difference in the expression of BMP-2 in bone tissues of broken ends of fractured bone between the 4 groups(0.11+/-0.02,0.15+/-0.02,0.24+/-0.03,0.28+/-0.02,F=80.017,P=0.000).Further pairwise comparison showed that the expression of BMP-2 in bone tissues was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.004,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.000),and was lower in JGQLJN group compared to JGXJW group(P=0.004).At 7 days after the beginning of drug intervention,there was statistical difference in the expression of VEGF in bone tissues of broken ends of fractured bone between the 4 groups(0.11+/-0.02,0.14+/-0.02,0.26+/-0.01,0.27+/-0.04,F=69.567,P=0.000).Further pairwise comparison showed that the expression of VEGF in bone tissues was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.015,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.000),and there was no statistical difference between JGQLJN group and JGXJW group(P=0.905).At 14 days after the beginning of drug intervention,there was statistical difference in the expression of VEGF in bone tissues of broken ends of fractured bone between the 4 groups(0.11+/-0.02,0.15+/-0.02,0.25+/-0.03,0.28+/-0.02,F=72.334,P=0.000).Further pairwise comparison showed that the expression of VEGF in bone tissues was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.026,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.000),and there was no statistical difference between JGQLJN group and JGXJW group(P=0.071).At 21 days after the beginning of drug intervention,there was statistical difference in the expression of VEGF in bone tissues of broken ends of fractured bone between the 4 groups(0.11+/-0.02,0.15+/-0.02,0.24+/-0.02,0.27+/-0.05,F=39.739,P=0.000).Further pairwise comparison showed that the expression of VEGF in bone tissues was lower in sham-operated group compared to model group,JGQLJN group and JGXJW group(P=0.000,P=0.000,P=0.000),and was lower in model group compared to JGQLJN group and JGXJW group(P=0.000,P=0.000),and was lower in JGQLJN group compared to JGXJW group(P=0.029).Conclusion:JGXJW can increase the serum contents of P and ALP and promote the expression of BMP-2 and VEGF in bone tissues to promote the osteoblast proliferation,which may be the mechanisms of action for promoting fracture healing in rats.However,its specific mechanism of action needs to be further studied.

参考文献/References:

[1] 潘元珍,刘超群,周国林.闭合性骨折早期应用中药熏洗、外敷的疗效观察[J].中国实验方剂学杂志,2013,19(13):333-335.
[2] 朱建富,郑海荣,曾焕友.骨折术后患者应用活血化瘀类药物促进骨折愈合的近期与远期疗效[J].辽宁中医杂志,2015,42(3):509-511.
[3] 林越,张宁,刘世巍,等.补肾活血方对 hPTH(1-34)干预下小鼠成骨细胞 MC3T3-E1增殖及分化的影响[J].中华临床医师杂志,2012,6(11):3065-3068.
[4] 章晓云,陈跃平,龙飞攀,等.手法复位小夹板固定结合中医三期辨证用药治疗伸直型桡骨远端骨折367例[J].中医正骨,2014,26(12):37-39.
[5] 梁春雨,张柳,赵文国,等.前交叉韧带切断对卵巢切除大鼠股骨骨折愈合的影响[J].中国骨质疏松杂志,2005,11(2):146-155.
[6] 赵亮,张晨.续断骨伤合剂在促进骨折愈合中对血生化指标的影响[J].湖北中医药大学学报,2011,13(1):11-13.
[7] BOYAN BD,SWAIN LD,SCHWARTZ Z,et al.Epithelial cell lines that induce bone formation in vivo produce alkaline phosphatase-enriched matrix vesicles in culture[J].Clin Orthop Relat Res,1992,(277):266-276.
[8] 梁伟,吕天成,李理,等.降钙素基因相关肽对骨质疏松性骨折愈合影响的体外研究[J].中华骨科杂志,2017,37(6):353-358.
[9] 童安莉,陈璐璐,丁桂芝.成骨细胞骨形成机制研究进展[J].中国骨质疏松杂志,1999,5(3):60-64.
[10] COUGHLIN SR.Thrombin signalling and protease-activated receptors[J].Nature,2000,407(681):258-264.
[11] LOI F,CóRDOVA LA,PAJARINEN J,et al.Inflammation,fracture and bone repair[J].Bone,2016,86:119-130.
[12] 周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(8):7-10.
[13] CHEN D,HARRIS MA,ROSSINI G,et al.Bone morphogenetic protein 2(BMP-2)enhances BMP-3,BMP-4,and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts[J].Calcif Tissue Int,1997,60(3):283-290.
[14] 赵明,王信会,周延伸.rhBMP-2成熟肽在大肠杆菌中的表达及其诱导成骨活性[J].生物化学杂志,1994,10(3):319.
[15] 吴志明,王东,罗华云,等.骨科基础研究的奠基者Marshall R.Urist[J].实用骨科杂志,2007,13(4):246-247.
[16] GARRISON KR,SHEMILT I,DONELL S,et al.Bone morphogenetic protein(BMP)for fracture healing in adults[J].Cochrane Database Syst Rev,2010,65(6):6950.
[17] 姚明智.接骨七厘片对四肢骨折愈合过程中血清骨形态发生蛋白-2的影响[J].中国当代医药,2015,22(9):94-96.
[18] 张佩,董路珏,李义凯.新伤续断汤对成骨细胞增殖及骨形态发生蛋白的影响[J].广州中医药大学学报,2016,33(1):92-97.
[19] 李科伦,赵政,陈学文,等.骨折延迟愈合患者血清多项因子及微循环指标的变化研究[J].中华全科医学,2014,12(11):1778-1779.
[20] CARMELIET P,CEHER D.Mceecular analysist of bolld vessel formation and disease[J].Am J Physiol,1997,273(5 Pt2):2091-2104.
[21] 康献刚,王志强.骨折愈合过程中细胞因子的作用[J].中国修复重建外科杂志,2008,22(7):877-879.
[22] 纪经涛,胡永成,夏群,等.血管内皮生长因子和骨形态发生蛋白在骨组织工程中的作用[J].中国组织工程研究,2015,19(33):5356-5363.
[23] EINHORN TA,GERSTENFELD LC.Fracture healing: mechanisms and interventions[J].Nat Rev Rheumatol,2015,11(1):45-54.
[24] 王琴,易美彤,曾敏.愈骨胶囊促进兔骨折愈合的分子机制初探[J].中成药,2013,35(11):2337-2341.
[25] 杨震,吴兴林,李建扬,等.BMP-2和VEGF基因活化纳米骨浆对去势雌性山羊椎骨骨质影响[J].中华显微外科杂志,2016,19(39):469-473.
[26] 周正楠,张岩,邱旭升,等.骨折愈合过程中VEGF的表达与调控及其作用的研究进展[J].中国矫形外科杂志,2015,23(24):2248-2251.

相似文献/References:

[1]于满秋,侯仁平,毕宏政.骨折端微动数字化测控系统在胫腓骨中下段双骨折外固定支架固定后早期负重锻炼中的应用[J].中医正骨,2016,28(08):39.
[2]杨虎,郑宇,王通,等.低氧诱导因子-1α促进骨折早期愈合的机制[J].中医正骨,2024,36(06):52.

备注/Memo

备注/Memo:
通讯作者:侯德才 E-mail:lnzyhdc@163.com
更新日期/Last Update: 2018-03-10